Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

The efficacy of ultrasonography-guided transvaginal needle biopsy for the preoperative diagnosis of uterine neoplasm: a case report of a young woman with low-grade endometrial stromal sarcoma and literature review.

Fukushima journal of medical science·2026
Same author

A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial.

The lancet. Diabetes & endocrinology·2026
Same author

Suggestive characteristic change of CD123<sup>+</sup>dendritic cells in Kikuchi-Fujimoto Disease.

Journal of clinical and experimental hematopathology : JCEH·2026
Same author

Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND.

Diabetes care·2026
Same author

Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.

The New England journal of medicine·2025
Same author

A Novel Mouse Model for Developmental and Epileptic Encephalopathy by Purkinje Cell-Specific Deletion of <i>Scn1b</i>.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2025

Related Experiment Video

Updated: Aug 7, 2025

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.0K

Ovarian strumal carcinoid: a case report.

Masaru Kanasugi1, Hiroshi Nishiyama1, Minoru Sanpei1

  • 1Department of Obstetrics and Gynecology, Iwaki Kyouritsu Hospital.

Fukushima Journal of Medical Science
|March 6, 2023
PubMed
Summary

Strumal carcinoid is a rare ovarian tumor, often arising from mature teratomas. This case highlights a 56-year-old woman successfully treated for stage IA strumal carcinoid, with no recurrence after six years.

Keywords:
case reportclinical diagnosishistopathological featureovarian strumal carcinoidtreatment

More Related Videos

Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells
08:17

Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells

Published on: December 9, 2016

10.7K
Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
14:25

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

17.4K

Related Experiment Videos

Last Updated: Aug 7, 2025

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.0K
Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells
08:17

Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells

Published on: December 9, 2016

10.7K
Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
14:25

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

17.4K

Area of Science:

  • Gynecologic Oncology
  • Pathology
  • Endocrinology

Background:

  • Ovarian carcinoid tumors are rare, originating from teratomas or dermoid cysts, with variable malignancy.
  • Strumal carcinoid and mucinous carcinoid are specific subtypes of ovarian carcinoid tumors.
  • These tumors can manifest in various ovarian contexts, including mature teratomas and cystadenomas.

Observation:

  • A 56-year-old woman presented with a large pelvic mass (11 cm) detected via ultrasonography.
  • Preoperative tumor markers (CA125, CEA) were elevated, raising suspicion for ovarian cancer.
  • Initial intraoperative frozen-section suggested mucinous adenocarcinoma.

Findings:

  • Final permanent-section histopathology confirmed a diagnosis of strumal carcinoid of the ovary.
  • The tumor was staged as IA (International Federation of Gynecology and Obstetrics 2014).
  • The patient underwent total hysterectomy and bilateral salpingo-oophorectomy, with additional omentectomy and lymphadenectomy.

Implications:

  • This case demonstrates a favorable long-term outcome for stage IA strumal carcinoid.
  • Accurate histopathological diagnosis is crucial for appropriate management of rare ovarian tumors.
  • Early detection and surgical intervention can lead to successful treatment and prolonged disease-free survival.